AbbVie Inc. (ABBV) is a publicly traded company in the Unknown sector. Across all available filings, 33 corporate insiders have executed 1004 transactions totaling $733.2M, demonstrating a bearish sentiment with -$703.9M in net insider flow. The most recent transaction on Aug 12, 2025 involved a transaction of 42,370 shares valued at $2.3M.
No significant insider buying has been recorded for ABBV in the recent period.
No significant insider selling has been recorded for ABBV in the recent period.
Based on recent SEC filings, insider sentiment for ABBV is bearish with an Insider Alignment Score of 2/100 and a net flow of -$703.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at AbbVie Inc. (ABBV) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 33 insiders are actively trading ABBV stock, having executed 1004 transactions in the past 90 days. The most active insider is Richard A. Gonzalez (Executive), who has made 153 transactions totaling $412.1M.
Get notified when executives and directors at ABBV file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | Saleki-gerhardt Azita | Executive | Option Exercise | 42,370 | $54.86 | $2.3M | Large |
| Aug 12, 2025 | Saleki-gerhardt Azita | Executive | Sale | 42,370 | $198.42 | $8.4M | Large |
| Aug 5, 2025 | Donoghoe Nicholas | Executive | Sale | 3,234.17 | $198.27 | $641.2K | Large |
| Aug 5, 2025 | Donoghoe Nicholas | Executive | Sale | 10,061 | $198.59 | $2.0M | Large |
| Sep 24, 2024 | Saleki-gerhardt Azita | Executive | Gift | 25,630 | $N/A | $0 | |
| Aug 5, 2024 | A. Gonzalez Richard | Executive | Sale | 66,500 | $186.52 | $12.4M | Large |
| Jul 17, 2024 | A. Gonzalez Richard | Executive | Sale | 282,845 | $175.00 | $49.5M | Large10b5-1 |
| Jul 17, 2024 | A. Gonzalez Richard | Executive | Option Exercise | 87,050 | $61.36 | $5.3M | Large10b5-1 |
| Jul 17, 2024 | A. Gonzalez Richard | Executive | Option Exercise | 76,377 | $93.50 | $7.1M | Large10b5-1 |
| Jul 17, 2024 | A. Gonzalez Richard | Executive | Option Exercise | 119,418 | $79.02 | $9.4M | Large10b5-1 |
| May 3, 2024 | H. Waddell Frederick | Executive | Award | 1,322 | $N/A | $0 | |
| May 3, 2024 | F. Tilton Glenn | Executive | Award | 1,322 | $N/A | $0 | |
| May 3, 2024 | B. Roberts Rebecca | Executive | Award | 1,322 | $N/A | $0 | |
| May 3, 2024 | B. Meyer Melody | Executive | Award | 1,322 | $N/A | $0 | |
| May 3, 2024 | J. Hart Brett | Executive | Award | 1,322 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 324 | $718.6M | 57.7% |
Payment(F) | 114 | $283.9M | 22.8% |
Exercise(M) | 84 | $216.0M | 17.4% |
Purchase(P) | 21 | $14.6M | 1.2% |
Award(A) | 410 | $11.1M | 0.9% |
Disposition(D) | 1 | $496.2K | 0.0% |
Gift(G) | 49 | $0 | 0.0% |
Will Acquisition(W) | 1 | $0 | 0.0% |
Insider selling pressure at AbbVie Inc. has increased, with 33 insiders executing 1004 transactions across all time. Total sales of $718.6M significantly outpace purchases of $14.6M, resulting in a net outflow of $703.9M. This selling activity appears largely discretionary, which may warrant closer attention from investors.